Dr. Chuanzheng Sun 孙传政
Chief Physician
Department of Head and Neck Surgical Oncology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of thyroid tumors, oral and maxillofacial tumors, and laryngeal cancer.
Dr. Sun is a Chief Physician, holds a PhD, and serves as a doctoral supervisor. Dr. Sun leads the Second Department of Head and Neck Surgery at Yunnan Cancer Hospital. Recognized as a leading medical talent and academic leader in Yunnan Province, Dr. Sun was selected for the Yunnan Ten Thousand Talents Plan "Famous Doctor" special project and leads a provincial innovation team for head and neck tumor research.
Professional roles
- Standing Committee Member, Oral and Maxillofacial Tumor Integrated Medicine Professional Committee, China Anti-Cancer Association
- Member, First Plastic and Reconstructive Surgery Group, Head and Neck Tumor Professional Committee, China Anti-Cancer Association
- Member, Tumor Plastic Surgery Professional Committee, China Anti-Cancer Association
- Vice Chair, Trauma Repair and Plastic Surgery Branch, Yunnan Association of Plastic and Aesthetic Surgery
Name order: in Chinese the family name comes first (Sun Chuanzheng). Papers usually list the name as Chuanzheng Sun or Sun C.
Selected publications
42 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Surg Oncol, 2026 (senior author): Clinical Efficacy of Neurorrhaphy in Anterolateral Thigh Flap Reconstruction for Tongue Cancer Defects: A Randomized Controlled Trial. PubMed 42616334
- Eur Arch Otorhinolaryngol, 2026 (senior author): Clinicopathological characteristics, incidence trends, and prognostic factors of salivary gland secretory carcinoma: a SEER database analysis (2011-2021). PubMed 41524932
- JPRAS Open, 2025 (senior author): Application of flap economics in head and neck reconstruction. PubMed 41235350
- J Transl Med, 2025 (senior author): CRISPR/Cas9 library screening reveals that STK19 has synergistic antitumor effects when combined with cisplatin on tongue squamous cell carcinoma. PubMed 41121307
- Biochim Biophys Acta Mol Cell Res, 2025 (senior author): Carcinoma-associated fibroblast-derived exosomes lncRNA RORA-AS1 facilitates radiotherapy resistance of oral squamous cell carcinoma through the IFITM1/STAT axis. PubMed 40588135
- Front Endocrinol (Lausanne), 2024 (senior author): A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis. PubMed 39104813
- Front Genet, 2021 (senior author): Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. PubMed 34539737
- Cancer Cell Int, 2021 (senior author): Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma. PubMed 34266418
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion